Guardant Health, Inc. (GH) Q3 2025 Earnings Call October 29, 2025 4:30 PM EDT
Company Participants
Zarak Khurshid – Vice President of Investor Relations
Helmy Eltoukhy – Co-Founder, Co-CEO & Chairman
AmirAli Talasaz – Co-CEO & Director
Michael Bell – Chief Financial Officer
Conference Call Participants
Bradley Bowers – Mizuho Securities USA LLC, Research Division
Douglas Schenkel – Wolfe Research, LLC
Puneet Souda – Leerink Partners LLC, Research Division
Subhalaxmi Nambi – Guggenheim Securities, LLC, Research Division
Patrick Donnelly – Citigroup Inc., Research Division
Tycho Peterson – Jefferies LLC, Research Division
William Bonello – Craig-Hallum Capital Group LLC, Research Division
Mark Massaro – BTIG, LLC, Research Division
Casey Woodring – JPMorgan Chase & Co, Research Division
Kyle Mikson – Canaccord Genuity Corp., Research Division
Luke Sergott – Barclays Bank PLC, Research Division
Daniel Brennan – TD Cowen, Research Division
Daniel Arias – Stifel, Nicolaus & Company, Incorporated, Research Division
Presentation
Operator
Good afternoon. Thank you for attending the Guardant Health Q3 2025 Earnings Call. My name is Cameron, and I’ll be your moderator for today. [Operator Instructions]
And I would now like to pass the conference over to your host, Zarak Khurshid with Guardant Health. You may proceed.
Zarak Khurshid
Vice President of Investor Relations
Thank you. Earlier today, Guardant Health released financial results for the quarter ended September 30, 2025. Joining me today from Guardant are Helmy Eltoukhy, Co-CEO; AmirAli Talasaz, Co-CEO; and Mike Bell, Chief Financial Officer.
Before we begin, I’d like to remind you that during this call, management will make forward-looking statements within the meaning of federal securities laws. These statements involve material risks and uncertainties that could cause actual results or events to materially differ from those anticipated. This call will also include a discussion of non-GAAP financial measures, which are adjusted to exclude certain specified items, additional information regarding material risks and uncertainties as well as the non-GAAP financial reconciliation to most directly
Read the full article here
